The Race To Develop A COVID-19 Vaccine: The Finish Line Approaches
A Visual Guide And Q&A On The Frontrunners
Updated: a graphic tracker of key developments from the leading vaccine candidates.
You may also be interested in...
Meanwhile, seven former US FDA commissioners issue joint plea for trust in the scientific integrity of the agency.
Phase III protocols for COVID-19 vaccine candidates from Pfizer/BioNTech, Moderna, AstraZeneca and Johnson & Johnson are similar – but definitely not the same.
Novavax has granted Serum Institute rights to develop, manufacture and commercialize its COVID-19 vaccine candidate in selected regions, in another endorsement of the Indian group's capabilities. The agreement, which expands on an earlier association, gives Serum exclusive marketing rights in India until the deal ends and non-exclusive rights for developing countries to the end of the pandemic, with the US firm getting half of net revenue.